Wolverine Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Wolverine Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,200	Closed	-$98.9K	–	2087
2022 Q4	$98.9K	Hold	2,200	–	–	﹤0.01%	1276
2022 Q3	$105K	Hold	2,200	–	–	﹤0.01%	1419
2022 Q2	$130K	Hold	2,200	–	–	﹤0.01%	1320
2022 Q1	$255K	Sell	2,200 -8,300	-79%	-$969K	﹤0.01%	1117
2021 Q4	$1.58M	Buy	10,500 +2,200	+27%	+$297K	0.01%	631
2021 Q3	$990K	Hold	8,300	–	–	0.01%	729
2021 Q2	$808K	Hold	8,300	–	–	0.01%	731
2021 Q1	$732K	Hold	8,300	–	–	0.01%	762
2020 Q4	$794K	Buy	+8,300	New	+$855K	0.01%	712

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wolverine Asset Management's TNDM Position: Q3 2021 in Review

Wolverine Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2021, closing a stake of 77 shares — an estimated $8.48K sold.

Wolverine Asset Management first reported a position in TNDM in Q2 2020 and held it in 4 quarters. The position peaked at $408K in Q4 2020. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

Wolverine Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2021 after selling out during the quarter.
Wolverine Asset Management sold 77 Tandem Diabetes Care shares in Q3 2021, an estimated $8.48K.
Wolverine Asset Management first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 4 quarters.
Wolverine Asset Management's Tandem Diabetes Care position peaked at $408K in Q4 2020.
337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.